Pulse Bio files U.S. marketing application for CellFX system

|About: Pulse Biosciences, Inc. (PLSE)|By:, SA News Editor

Pulse Biosciences (NASDAQ:PLSE) has filed an application with the FDA seeking 510(k) clearance for its CellFX System for removing benign skin lesions.

CellFX delivers non-thermal energy pulses that disrupts the functions of targeted cells while sparing neighboring tissues.

Subscribe for full text news in your inbox